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Abstract 
Attention deficit hyperactivity disorder (ADHD) has a complex etiology although theories 
associated with disturbances in dopaminergic and noradrenergic activity are most commonly cited. 
The importance of these catecholamines in ADHD is supported by its effective treatment utilising 
stimulant and non-stimulant medications that modify their activity. Recently there has been interest 
in oxidative and nitrosative stress (O&NS) in ADHD and its potential to contribute to this 
condition. In this article, research investigating O&NS in ADHD is reviewed and its impact on 
catecholaminergic activity and neurological structure is discussed. Lifestyle, environmental, 
psychological and nutritional influences on O&NS in people with ADHD are reviewed and 
evidence for the therapeutic efficacy of antioxidant-related therapies is assessed. A selection of 
interventions with antioxidant mechanisms are presented as potential options for the treatment of 
ADHD. However, further research is required to help elucidate the role of O&NS and antioxidants 
for the prevention and management of ADHD.  
  
Attention deficit hyperactivity disorder (ADHD) is a common behavioural disorder affecting 5 to 
7 percent of school-age children (Willcutt 2012) and 2 to 5 percent of adults (Fayyad et al. 2007; 
Simon et al. 2009). It has a complex etiology although theories associated with disturbances in 
dopaminergic and noradrenergic neurotransmission have been the most predominant. In people 
with ADHD, the prefrontal cerebral cortex, caudate, and cerebellum have emerged as the primary 
areas showing deficits (Durston 2003; Seidman et al. 2005). These areas are important for the 
regulation of attention, thoughts, emotions, and behaviour. The network of activity in these areas is 
believed to be maintained by the neurotransmitters dopamine and noradrenaline (Sharma and 
Couture 2014). 
ADHD is most commonly treated with stimulant medications such as methylphenidate and 
amphetamines, non-stimulants such as atomoxetine, and alpha2-adrenergic agonists such as 
clonidine and guanfacine. Through their effects on dopamine and noradrenaline transporters, 
stimulants inhibit the reuptake of dopamine and noradrenaline, thereby increasing the extracellular 
levels of these neurotransmitters. These stimulants also inhibit monoamine oxidase, the enzyme 
that metabolises these catecholamines (Wilens et al. 2011). Atomoxetine works as a selective 
reuptake inhibitor of noradrenaline leading to its increased extracellular concentration (Garnock-
Jones and Keating 2009). 
While effective, these medications are associated with several adverse effects. These include loss 
of appetite, growth delay and sleep disturbances (Cortese et al. 2013). It is important to note that 
despite their widely accepted short-term efficacy, the long-term effectiveness of pharmacological 
treatments on social, educational and occupational functioning in people with ADHD continues to 
be debated (Huang and Tsai 2011; Langberg and Becker 2012; Nijmeijer et al. 2008). On a positive 
note, recent analyses using the Swedish national registrar suggests that long-term stimulant use in 
people with ADHD is associated with reduced rates of substance use, criminality, and serious traffic 
accidents (Chang et al. 2014a; Chang et al. 2014b; Lichtenstein et al. 2012). 
Despite wide appreciation of catecholaminergic theories associated with ADHD, there has been 
increased research into other biological mechanisms associated with ADHD. For example, in 
psychiatry there has been interest in immune-inflammatory pathways and oxidative and nitrosative 
stress (O&NS). In particular, it has been confirmed through recent meta-analyses that depression is 
associated with increased O&NS (Howren et al. 2009; Palta et al. 2014). In a meta-analysis of twenty-
three studies with 4980 participants, Palta et al. (2014) confirmed a Cohen’s d effect size of 0.55 for 
the association between depression and oxidative stress; and a smaller but statistically significant 
effect for the association between depression and antioxidant status markers (Cohen’s d = -0.24). 
Increased O&NS has also been found in bipolar disorder (Andreazza et al. 2008; Brown et al. 2014), 
with the results of a recent meta-analysis confirming increased lipid peroxidation, DNA/RNA 
damage, and nitric oxide in people with bipolar disorder compared to healthy controls (Brown et al. 
2014). Increases O&NS has also been found in people with anxiety disorders (Hassan et al. 2014) 
and schizophrenia (Emiliani et al. 2014).  
The purpose of this article is to review O&NS in ADHD, potential causes for O&NS, and how 
O&NS may impact on the etiology of ADHD. Finally, antioxidant therapies for the treatment of 
ADHD are reviewed and the potential of various antioxidant therapeutic options are discussed. 
What is oxidative and nitrosative stress? 
Reactive oxygen (ROS) and reactive nitrogen species (RNS), such as superoxide, nitric oxide, 
peroxynitrite and hydrogen peroxide are unstable molecules that can react with other cells in the 
body. They are generated during normal cellular metabolism, mainly formed within the 
mitochondria. ROS and RNS can also be generated from ultraviolet light irradiation, environmental 
pollutants, and by neutrophils, eosinophils and macrophages during inflammation. Via their 
influence on proteins, fatty acids and DNA, ROS and RNS have numerous essential physiological 
roles involved in the regulation of cellular function (Rahman 2007).  
Under normal conditions, ROS and RNS are regulated by a balancing system comprising 
antioxidants, antioxidant enzymes and proteins. Antioxidants remove ROS and RNS by scavenging 
radicals and decreasing their production. Examples of scavenger antioxidants are coenzyme Q10 
(CoQ10), vitamin C and E, and glutathione. ROS may also be neutralised by different antioxidant 
enzymes such as superoxide dismutase, glutathione peroxidase and catalase. Some proteins 
including acute phase proteins such as albumin, transferrin, haptoglobin and ceruloplasmin also 
function as antioxidants by binding ROS and RNS (Maes et al. 2011).  
A state of O&NS occurs when there is an imbalance between ROS/RNS and antioxidant 
defences. Antioxidant defences may be compromised due to lowered antioxidant concentrations in 
the body and/or lowered activity of antioxidant enzymes. O&NS can be detrimental to the body 
leading to structural and functional changes producing cellular injury. An excess of ROS and RNS 
can cause damage to fatty acids, proteins and DNA. O&NS also has the capacity to damage 
mitochondrial defence systems, further perpetuating O&NS. Some organs, such as the brain, are 
more vulnerable to the detrimental effects of O&NS because of its high level of oxygen utilisation, 
high lipid content, and lower antioxidant concentration (Ikonomidou and Kaindl 2011). 
Evidence for oxidative/ nitrosative stress (O&NS) in ADHD 
Although findings are inconsistent, in a recent meta-analysis it was confirmed that ADHD is 
associated with increased oxidative stress (Joseph et al. 2013). Children and adults with ADHD 
have, on the whole, increased O&NS biomarkers in blood, urine and saliva. For example, elevated 
levels of malondialdehyde (MDA), a marker of lipid peroxidation have been found in children 
(Ceylan et al. 2010) and adults (Bulut et al. 2013; Bulut et al. 2007) with ADHD. However, lowered 
concentrations of MDA have also been identified in people with ADHD (Oztop et al. 2012; Spahis et 
al. 2008). There has also been confirmation of increased nitrosative stress as demonstrated by an 
increased concentration of nitric oxide in children (Ceylan et al. 2010) and adults (Selek et al. 2008), 
and increased activity of nitric oxide synthase in children (Ceylan et al. 2012). A summary of 
findings examining O&NS biomarkers in people with ADHD is presented in Table 1. 
 
<<Insert Table 1 near here>> 
 
In the same meta-analysis by Joseph and colleagues (2013) it was concluded that there was no 
evidence of discrepancy in antioxidant activity between people with ADHD and healthy, matched 
controls. As demonstrated in Table 2, investigations into antioxidant activity are generally 
inconsistent in people with ADHD. On the whole, differences have been observed although the 
direction of change is inconsistent. The discrepant findings may be due processes associated with 
the onset of an antioxidant defence system. That is, increases in antioxidant activity may not 
necessarily reflect a premorbid increased concentration but an upregulation in activity to combat 
increased free radical activity. 
 
<<Insert Table 2 near here>> 
 
While the findings to date suggest increased O&NS in people with ADHD, they are tempered by 
continued inconsistences. Biomarker measurement in psychiatry is still in its infancy, particularly 
relating to peripheral markers associated with O&NS. As observed in Tables 1 and 2 several 
markers have been measured, but no uniform ‘ideal’ biomarker or collection of biomarkers has been 
agreed upon. Currently MDA and markers associated with nitric oxide have received the most 
attention and most consistent findings. Antioxidant biomarkers such as paraoxonase-1 (PON-1) and 
superoxide dismutase also show promise as potentially reliable markers.  
Collection, storage and measurement procedures also vary significantly across studies and there 
is still no agreement on ‘gold standard’ and user friendly collection and measurement protocols. In 
addition, further investigation is required to determine the extent of O&NS across gender and age. 
It is also plausible that O&NS is associated with certain ADHD subtypes and/or symptoms but this 
has not yet been adequately explored due to a lack of adequately powered studies. 
Potential causes of O&NS in ADHD  
While there is evidence of increased O&NS in ADHD, correlation does not confirm causation. 
O&NS can theoretically affect several biological pathways associated with ADHD, although it is 
equally plausible that other lifestyle, environmental, psychological and genetic factors associated 
with ADHD account for the observed increases. That is, greater O&NS may simply be an artefact 
associated with these various factors and have little to do with the actual etiology of ADHD. 
Alternatively, O&NS may play an important role in disturbing biological mechanisms associated 
with ADHD. Lifestyle, environmental, psychological and nutritional factors that may contribute to 
the increased O&NS observed in ADHD are reviewed below. 
Diet quality is often believed to influence ADHD symptoms. Food colourings, additives, and 
unhealthy food choices are commonly reported to contribute to ADHD symptomatology, leading 
researchers to investigate the treatment efficacy of restriction and elimination diets (Heilskov Rytter 
et al. 2014; Nigg and Holton 2014). In prospective studies, consuming a Western dietary pattern or a 
high junk food diet during early childhood was associated with an increased risk of ADHD in later 
childhood and adolescence (Howard et al. 2011; Wiles et al. 2009). If diet has a role in the 
establishment of ADHD, prevalence rates should therefore vary across geographic regions with 
differing dietary patterns. However, no adequately controlled study has been identified 
investigating this area.  
O&NS can be influenced by dietary patterns, with consistent findings of increased O&NS 
associated with Western dietary patterns and lowered O&NS associated with Mediterranean and 
traditional diets (Berk et al. 2013b; Lopresti et al. 2013). The consumption of synthetic food 
colourings and additives are also likely to impact on O&NS activity (Amin et al. 2010; El-Wahab 
and Moram 2013). In an animal study, the administration of several synthetic food colorants and 
flavour additives lowered blood and liver concentrations of reduced glutathione, glutathione-S-
transferase and superoxide dismutase (El-Wahab and Moram 2013). Tartrazine administration for 
60 days to male rats reduced testicular concentrations of superoxide dismutase, catalase, 
glutathione peroxidase, and glutathione reductase (Visweswaran and Krishnamoorthy 2012). These 
synthetic colorants can alter concentrations of zinc, iron, copper and manganese which are all 
essential cofactors for antioxidant enzymes (Cemek et al. 2014; Visweswaran and Krishnamoorthy 
2012). Food colourings are also associated with increased immune reactivity which may be another 
mechanism associated with O&NS (Vojdani and Vojdani 2015). 
Sleep disturbances are common in children with ADHD. This is characterised by sleep onset 
difficulties, sleep-disordered breathing, and frequent night-time awakenings (Hvolby 2014; Sedky 
et al. 2014). While there continues to be uncertainty about the direction of this ADHD-sleep 
relationship, it has been confirmed that sleep problems are associated with increased O&NS 
(Boudjeltia et al. 2011; Gulec et al. 2012), thereby presenting an additional contributory cause for the 
increased O&NS observed in ADHD.  
Exercise influences antioxidant activity and consequent O&NS (Cooper et al. 2002; Radak et al. 
2008). Although research is limited, television watching and computer usage is increased, and 
participation in sports is decreased in children with ADHD (Bener and Kamal 2014; Lingineni et al. 
2012). Early television watching is also associated with attentional problems in later childhood 
(Cheng et al. 2010; Christakis et al. 2004), although this finding is inconsistent as null associations 
have also been found in several studies (Ferguson 2011; Stevens and Mulsow 2006) 
ADHD is regularly associated with deficiencies in several nutrients influencing immune-
inflammatory pathways and O&NS. Omega-3 essential fatty acids (EFAs) have effective anti-
inflammatory and antioxidant effects and are consistently lowered in people with ADHD (Hawkey 
and Nigg 2014). Zinc has numerous biological roles in the body and has strong antioxidant activity 
(Prasad 2014). Zinc deficiency and reduced zinc concentrations are often found in people with 
ADHD (Arnold and DiSilvestro 2005), and this has been confirmed in a meta-analysis by Scassellati 
and colleagues (2012). More recently, lowered vitamin D levels and vitamin D deficiency have also 
been reported in people with ADHD (Bener and Kamal 2014; Goksugur et al. 2014). Vitamin D has 
significant immune-modulating effects (Gunville et al. 2013) and supplementation is associated 
with a reduction in oxidative stress (Shab-Bidar et al. 2014).  
ADHD is also associated with an increased exposure to prenatal smoking (Keyes et al. 2014; Zhu 
et al. 2014), and post-natal exposure to lead and other environmental pollutants (Polanska et al. 
2013; Yolton et al. 2014). Nicotine (Vargas et al. 2013) and lead exposure (Patra et al. 2011) can 
significantly increase free radical activity and subsequent O&NS. 
Psychiatric disorders such as depression, anxiety conditions and bipolar disorder are all 
associated with increased O&NS (Andreazza et al. 2008; Hassan et al. 2014; Palta et al. 2014). As 
these disorders have an increased comorbidity with ADHD (Babcock and Ornstein 2009; Mao and 
Findling 2014), this could at least partly account for the increased O&NS observed in ADHD. In 
addition, several medical disorders, particularly atopic eczema and asthma, have an increased 
prevalence in people with ADHD (Buske-Kirschbaum et al. 2013; Schmitt et al. 2010), with early 
childhood eczema a risk factor for the development of ADHD (Chen et al. 2014). Eczema is 
associated with increased oxidative stress and inflammatory response (Sivaranjani et al. 2013). 
There is also preliminary research to suggest that coeliac disease is over-represented in people with 
ADHD (Niederhofer 2011; Niederhofer and Pittschieler 2006), although negative findings have also 
been reported (Gungor et al. 2013). However, these medical and psychiatric disease cannot solely 
account for the increased O&NS in ADHD as in several studies these comorbidities were 
adequately controlled for in analyses.  
Although in most of the cross-sectional studies cited above medication use was accounted for in 
statistical analyses, it is interesting to note that ADHD medications such as methylphenidate and 
atomoxetine have been shown in animal studies to influence antioxidant activity and O&NS. 
Findings are inconsistent with reports of positive (Schmidt et al. 2010; Schmitz et al. 2012a), adverse 
(Comim et al. 2014; Martins et al. 2006; Schmitz et al. 2012b) and null effects (Cöngöloğlu et al. 2006; 
Gomes et al. 2008). This makes conclusions about the impact of such medications on O&NS difficult 
as results seem to be influenced by treatment duration (acute versus chronic), age of population 
(young versus adult), brain region examined, biomarker measured, and dosage of drug 
administered. Further investigation in this area is required as it has potential treatment implications 
particularly relating to the role of adjuvant antioxidant-targeted treatments.  
How O&NS and inflammation might influence biological pathways associated 
with ADHD  
Structural deficits in the prefrontal cerebral cortex, caudate, and cerebellum are commonly 
observed in ADHD (Durston 2003; Seidman et al. 2005). Lower concentrations of neurotrophins 
such as brain-derived neurotrophin factor (BDNF) have also been identified in people with ADHD 
(Liu et al. 2014). BDNF has a critical role in hippocampal functioning, long-term potentiation for 
learning and memory, synaptic plasticity, neurogenesis, and neuroprotection (Leal et al. 2014). 
Damage to relevant brain structures and reduced concentrations of neurotrophin may at least be 
partly due to O&NS. The brain is particularly susceptible to O&NS because of its high oxygen 
utilisation and relatively low antioxidant concentration. The brain also has a high lipid 
concentration which is susceptible to damage from O&NS (Ikonomidou and Kaindl 2011). O&NS 
also seems to have detrimental effects on levels of BDNF (Jain et al. 2013; Zhang et al. 2014). Why 
damage resulting from O&NS occurs in selective brain regions associated with ADHD symptoms is 
yet to be determined but may be related to pre-existing genetic susceptibilities making these areas 
vulnerable to O&NS damage. The timing of O&NS during critical maturation periods associated 
with these structural brain regions may also be a factor and requires investigation. 
Dopamine, the primary neurotransmitter implicated in ADHD, is also influenced by O&NS. 
Elevated hydrogen peroxide suppresses striatal dopamine release (Avshalumov et al. 2005), and 
excess O&NS is involved in the degeneration of dopaminergic neurons (Tsang and Chung 2009). 
O&NS also influences dopamine receptor function (Sankhwar et al. 2013; Zeng et al. 2009). Nitric 
oxide also has an inhibitory effect on dopamine transporters and decreases hippocampal levels of 
dopamine (Kiss et al. 2004; Wegener et al. 2000). 
5,6,7,8- tetrahydrobiopterin (BH4) is a rate-limiting enzyme associated with the biosynthesis of 
serotonin and the catecholamines dopamine, adrenaline, and noradrenaline. Increased output of 
ROS in macrophages over an extended period can destroy BH4, leading to a reduced capacity for 
dopamine and other neurotransmitter synthesis (Sperner-Unterweger et al. 2014). Reduced BH4 
activity may therefore be another factor accounting for the dopaminergic and noradrenergic 
disturbances observed in people with ADHD.  
It is important to note that the relationship between dopamine, noradrenaline and O&NS is bi-
directional. While O&NS can influence levels of these neurotransmitters, these neurotransmitters 
have antioxidative and free radical scavenging properties (Yen and Hsieh 1997). Dopamine can also 
be easily oxidised into the metabolite dopamine quinone, which is highly reactive and can 
contribute to oxidative stress (Meiser et al. 2013; Miyazaki and Asanuma 2008).  
The potential for antioxidant-related therapies in ADHD 
Nutraceuticals and diet are the most well-recognised antioxidant therapeutic options. However, 
as noted in previous sections, O&NS can be caused by a large array of factors. Consequently, 
therapies that target these causes can also be classified as antioxidant therapies. For example, 
improvements in sleep, increased physical activity, and treatment of comorbid medical and 
psychiatric disorders may have antioxidant effects. These approaches should therefore be 
considered, particularly if they are found to have significance in an individual with ADHD. In fact, 
in several studies it has been confirmed that exercise (Wigal et al. 2013) and sleep interventions 
(Hvolby 2014) have the potential to improve a number of symptoms associated with ADHD. 
Whether changes in O&NS are necessary for symptomatic improvement is unknown at this time, as 
biomarkers are rarely examined during these interventions.  
More ‘traditional’ antioxidant therapies are derived from dietary, nutraceutical or 
pharmacological options. In several studies dietary interventions comprising elimination and 
restrictive diets have shown promise as effective treatments for ADHD (Nigg and Holton 2014; 
Stevenson et al. 2014). Although it requires significant effort and is difficult to maintain long-term, 
positive effects have been found following the implementation of very restrictive diets, such as the 
“few foods” diet (Pelsser et al. 2009). However, further research is required as the benefits of such 
interventions have been inconsistently confirmed in published meta-analyses. For example, a meta-
analysis on artificial food colour exclusion revealed statistically significant moderate effects on 
ADHD symptoms, but when studies were restricted to trials on populations with no or low 
medication intake findings became non-significant. A meta-analysis by the same research group on 
elimination diets for ADHD revealed an overall significant large effect size, but this again became 
non-significant when only studies using ‘probably-blinded assessments’ were analysed (Sonuga-
Barke et al. 2013). Stevenson and colleagues (2014) concluded that restricted elimination diets and 
artificial food colour elimination are potentially valuable treatments, but larger-scale, robust studies 
are required. Also requiring investigation are the mechanisms associated with such interventions. 
Beneficial effects on O&NS and inflammatory processes are likely as the consumption of a Western 
diet, and synthetic food colourings and additives are associated with increased O&NS (El-Wahab 
and Moram 2013; Lopresti et al. 2013). 
Although research is still preliminary, there is evidence that agents with antioxidant activity are 
effective treatments for ADHD. Pinus marinus (French maritime pine bark) has strong antioxidant 
activity and has support for the treatment of ADHD. In a randomised, double-blind placebo 
controlled study, Pinus marinus was more effective than a placebo in reducing hyperactivity, and 
improving attention and visual-motor coordination in children with ADHD (Dvořáková et al. 2007; 
Trebaticka et al. 2006). In another study on adults with ADHD, Pinus marinus was as effective as 
methylphenidate, although neither was more effective than the placebo (Tenenbaum et al. 2002). 
These lack of significant findings from the two active treatment conditions may be due to the short 
treatment period of 3 weeks. The crossover design used in this study, comprising a short washout 
period of 1 week may have also impacted on the findings, as there were significant positive effects 
from all treatment conditions. 
Zinc has strong antioxidant properties and also has support as a stand-alone treatment in 
reducing hyperactivity and impulsivity, but not inattention in children and adolescents with ADHD 
(Bilici et al. 2004). As an adjunct treatment to methylphenidate, zinc also enhanced treatment gains 
compared to methylphenidate and a placebo in children with ADHD (Akhondzadeh et al. 2004). 
However, in another randomised, double-blind, placebo-controlled study, zinc as a stand-alone or 
adjunctive treatment to methylphenidate was ineffective for treating ADHD symptoms (Arnold et 
al. 2011).   
N-acetylcysteine (NAC), a precursor to the antioxidant glutathione, was effective for the 
treatment of ADHD symptoms in adults with systemic lupus erythematosus (Garcia et al. 2013). 
Interest in NAC has increased recently following promising findings for the treatment of several 
psychiatric disorders such bipolar disorder, depression and schizophrenia (Berk et al. 2013a). When 
used in conjunction with flax seed, vitamin C was also effective for the treatment of ADHD 
symptoms in an open-label study (Joshi et al. 2006). 
In a meta-analysis by Block et al. (2011), omega-3 EFA supplementation, particularly 
formulations with higher doses of eicosapentaenoic acid, were confirmed to be modestly effective 
for the treatment of ADHD. The anti-inflammatory effects of fish oil are well recognised and in 
some clinical trials supplementation has been associated with reduced oxidative stress (Hariri et al. 
2012; Mori et al. 2003). 
While there is some support on the efficacy of the above-mentioned nutraceuticals, further high-
quality studies on well-defined ADHD populations, using large sample sizes are required to help 
clarify their short and long-term efficacy. Other potential antioxidants included vitamin C, vitamin 
E and CoQ10. In addition, other nutraceuticals with significant antioxidant activity that merit 
investigation in ADHD treatment trials include curcumin, green tea and resveratrol. The 
psychotropic effects of curcumin, in particular, are intriguing, and there has been some support for 
it efficacy in the treatment of depression (Lopresti et al. 2014). Because of demonstrated vitamin D 
deficiencies in people with ADHD, supplementation with this vitamin and/or replenishment via 
sunlight exposure is an additional area requiring investigation. In fact, it has been found that living 
in regions with high solar intensity is independently associated with a lower prevalence of ADHD 
(Arns et al. 2013). As a result of its potential immune-regulating effects, there has also been interest 
in probiotic supplementation for depression and anxiety (Dinan et al. 2013) and it presents as 
another option for future study. 
Conclusion and directions for future research 
 
<<Insert Figure 1 near here>> 
 
From research conducted so far, it seems that that ADHD is associated with increased O&NS. 
However, there continues to be inconsistency in findings and this may at least be partly attributed 
to differences in O&NS markers tested, samples used, populations examined, and testing and 
collection protocols utilised to examine relevant markers. Further investigation is therefore required 
to help clarify the relevance of O&NS in ADHD and its applicability for the prevention and 
treatment of ADHD. 
What remains uncertain is the importance of O&NS in ADHD. As reviewed in this article and 
summarised in Figure 1, several lifestyle, environmental, nutritional, psychological and medical 
factors can influence O&NS, and it remains to be determined whether increased O&NS is simply a 
mere consequence associated with these factors, or whether it contributes to the development or 
exacerbation of ADHD symptoms. Positive findings from treatment studies utilising antioxidant 
therapies suggest that O&NS may have some relevance in ADHD, although studies are small and 
require further validation through high-quality study designs, with large samples sizes. 
Examination of biomarker changes during intervention trials and their relationship to symptomatic 
change will also help clarify the relevance of O&NS in ADHD. 
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Table 1. Summary of oxidative stress biomarkers examined in people with ADHD 
Reference Sample size Mean 
age 
% male1 Psychotropic 
medication 
Oxidative stress 
biomarker measured 
Difference compared 
to controls 
Ceylan et al. (2012) 35 (A) 35 (C) 10 69 No Xanthine oxidase ↑ (serum) 
Ceylan et al. (2012) 35 (A) 35 (C) 10 69 No Adenosine deaminase ↑ (serum) 
Oztop et al. (2012) 
Spahis, et al. (2008) 
Ceylan et al. (2010) 
Bulut, et al. (2013) 
Bulut et al. (2007) 
30 (A) 30 (C) 
37 (A) 35 (C) 
35 (A) 35 (C) 
35 (A) 29 (C) 
20 (A) 21 (C) 
9 
9 
10 
25 
28 
75 
73 
69 
71 
70 
No 
No 
No 
Yes 
Yes 
Malondialdehyde ↓ (plasma) 
↓ (plasma) 
↑ (plasma) 
↑ (plasma) 
↑ (plasma) 
Oztop et al. (2012) 30 (A) 30 (C) 9 75 No Advanced oxidation 
protein products 
=  (plasma) 
Archana et al. (2012) 20 (A) 20 (C) 9 70 No Pseudocholinesterase ↑ (saliva) 
Ceylan et al. (2010) 
Varol Tas et al. (2006) 
Selek et al. (2008) 
35 (A) 35 (C) 
30 (A) 51 (C) 
20 (A) 21 (C) 
10 
9 
28 
69 
100 
70 
No 
Yes 
No 
Nitric oxide ↑ (plasma) 
↓ (serum) 
↑ (plasma) 
Ceylan et al. (2012) 35 (A) 35 (C) 10 69 No Nitric oxide synthase ↑ (serum) 
Oztop et al. (2012) 30 (A) 30 (C) 9 75 No 8-Oxo-2'-deoxyguanosine ↓ (plasma) 
Chovanova et al. (2006) 61 (A) 56 (C) 12 82 No 8-Oxoguanine ↑ (plasma) 
Selek et al. (2012) 
Karababa et al. (2014) 
50 (A) 31 (C) 
32 (A) 32 (C) 
25 
31 
70 
68 
No 
No 
Total oxidative status ↑ (plasma) 
= (plasma) 
Selek et al. (2012) 
Karababa et al. (2014) 
50 (A) 31 (C) 
32 (A) 32 (C) 
25 
31 
70 
68 
No 
No 
Oxidative stress index ↑ (plasma) 
= (plasma) 
(A) = ADHD; (C) = control; 1ADHD group only 
  
 
Table 2. Summary of antioxidants biomarkers examined in people with ADHD 
Reference Sample size Mean 
age 
% male1 Psychotropic 
medication 
Antioxidant biomarker 
measured 
Difference compared to 
controls 
Çelik et al. (2013) 
Ceylan et al. (2010) 
Ruchi et al. (2011) 
40 (A) 35 (C) 
35 (A) 35 (A) 
32 (A) 35 (C) 
10 
10 
9 
63 
69 
88 
No 
No 
No 
Catalase = (plasma) 
↑ (plasma) 
↓ (saliva) 
Çelik et al. (2013) 
Ceylan et al. (2012) 
40 (A) 35 (C) 
35 (A) 35 (C) 
10 
10 
63 
69 
No 
No 
Glutathione S-
transferase 
↑ (plasma) 
↓ (serum) 
Ceylan et al. (2010) 35 (A) 35 (C) 10 69 No Glutathione peroxidase ↓ (plasma) 
Ceylan et al. (2010) 
Russo (2010) 
Selek et al. (2008) 
35 (A) 35 (C) 
22 (A) 20 (C) 
20 (A) 21 (C) 
10 
10 
28 
69 
77 
70 
No 
No 
No 
Superoxide dismutase = (plasma) 
↓ (serum) 
↓ (plasma) 
Çelik et al. (2013) 
Ruchi et al. (2011) 
40 (A) 35 (C) 
32 (A) 35 (C) 
10 
9 
63 
88 
No 
No 
Antioxidant activity ↑ (plasma)  
↓ (saliva) 
Selek et al. (2012) 
Karababa et al. (2014) 
50 (A) 31 (C) 
32 (A) 32 (C) 
25 
31 
70 
68 
No 
No 
Total antioxidative 
status 
↑ (plasma) 
= (plasma) 
Archana et al. (2012) 20 (A) 20 (C) 9 70 No Ceruloplasmin =  (saliva) 
Bulut et al. (2013) 35 (A) 29 (C) 25 71 Yes Arylesterase ↓ (plasma) 
Ceylan et al. (2012) 
Oztop et al. (2012) 
Bulut et al. (2013) 
35 (A) 35 (C) 
30 (A) 30 (C) 
35 (A) 29 (C) 
10 
9 
25 
69 
75 
71 
No 
No 
Yes 
Paraoxonase-1 ↓ (serum) 
=  (plasma) 
↓ (plasma) 
Oztop et al. (2012) 
Archana et al. (2012) 
30 (A) 30 (C) 
20 (A) 20 (C) 
9 
9 
75 
70 
No 
No 
Thiol =  (plasma) 
↑ (saliva) 
(A) = ADHD; (C) = control; 1ADHD group only 
  
  
 
 
Figure 1. A theoretical summary of the effects of O&NS in ADHD and the potential role for antioxidant-
targeted interventions. Increased O&NS is observed in ADHD which may be caused by an array of lifestyle, 
environmental, nutritional, psychological and medical factors. Compromised brain structures and 
catecholaminergic neurotransmission observed in people with ADHD are theorised to at least be partly 
caused by the detrimental effects of O&NS. If O&NS is causally related to ADHD, interventions that reduce 
O&NS present as potential treatments options for ADHD.  
